Literature DB >> 19953226

In vitro and in vivo characterization of JNJ-31020028 (N-(4-{4-[2-(diethylamino)-2-oxo-1-phenylethyl]piperazin-1-yl}-3-fluorophenyl)-2-pyridin-3-ylbenzamide), a selective brain penetrant small molecule antagonist of the neuropeptide Y Y(2) receptor.

James R Shoblock1, Natalie Welty, Diane Nepomuceno, Brian Lord, Leah Aluisio, Ian Fraser, S Timothy Motley, Steve W Sutton, Kirsten Morton, Ruggero Galici, John R Atack, Lisa Dvorak, Devin M Swanson, Nicholas I Carruthers, Curt Dvorak, Timothy W Lovenberg, Pascal Bonaventure.   

Abstract

RATIONALE: The lack of potent, selective, brain penetrant Y(2) receptor antagonists has hampered in vivo functional studies of this receptor.
OBJECTIVE: Here, we report the in vitro and in vivo characterization of JNJ-31020028 (N-(4-{4-[2-(diethylamino)-2-oxo-1-phenylethyl]piperazin-1-yl}-3-fluorophenyl)-2-pyridin-3-ylbenzamide), a novel Y(2) receptor antagonist.
METHODS: The affinity of JNJ-31020028 was determined by inhibition of the PYY binding to human Y(2) receptors in KAN-Ts cells and rat Y(2) receptors in rat hippocampus. The functional activity was determined by inhibition of PYY-stimulated calcium responses in KAN-Ts cells expressing a chimeric G protein Gqi5 and in the rat vas deferens (a prototypical Y(2) bioassay). Ex vivo receptor occupancy was revealed by receptor autoradiography. JNJ-31020028 was tested in vivo with microdialysis, in anxiety models, and on corticosterone release.
RESULTS: JNJ-31020028 bound with high affinity (pIC(50) = 8.07 +/- 0.05, human, and pIC(50) = 8.22 +/- 0.06, rat) and was >100-fold selective versus human Y(1), Y(4), and Y(5) receptors. JNJ-31020028 was demonstrated to be an antagonist (pK(B) = 8.04 +/- 0.13) in functional assays. JNJ-31020028 occupied Y(2) receptor binding sites (approximately 90% at 10 mg/kg) after subcutaneous administration in rats. JNJ-31020028 increased norepinephrine release in the hypothalamus, consistent with the colocalization of norepinephrine and neuropeptide Y. In a variety of anxiety models, JNJ-31020028 was found to be ineffective, although it did block stress-induced elevations in plasma corticosterone, without altering basal levels, and normalized food intake in stressed animals without affecting basal food intake.
CONCLUSION: These results suggest that Y(2) receptors may not be critical for acute behaviors in rodents but may serve modulatory roles that can only be elucidated under specific situational conditions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19953226     DOI: 10.1007/s00213-009-1726-x

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  34 in total

1.  Effect of a selective neuropeptide Y Y(2) receptor antagonist, BIIE0246 on neuropeptide Y release.

Authors:  P J King; G Williams; H Doods; P S Widdowson
Journal:  Eur J Pharmacol       Date:  2000-05-12       Impact factor: 4.432

2.  Pharmacological validation of a novel animal model of anticipatory anxiety in mice.

Authors:  A Lecci; F Borsini; G Volterra; A Meli
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 3.  Neuropeptide Y in normal eating and in genetic and dietary-induced obesity.

Authors:  B Beck
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-07-29       Impact factor: 6.237

4.  Neuropeptide Y5 receptor antagonism does not induce clinically meaningful weight loss in overweight and obese adults.

Authors:  Ngozi Erondu; Ira Gantz; Bret Musser; Shailaja Suryawanshi; Madhuja Mallick; Carol Addy; Josee Cote; George Bray; Ken Fujioka; Harold Bays; Priscilla Hollander; Sandra M Sanabria-Bohórquez; WaiSi Eng; Bengt Långström; Richard J Hargreaves; H Donald Burns; Akio Kanatani; Takehiro Fukami; Douglas J MacNeil; Keith M Gottesdiener; John M Amatruda; Keith D Kaufman; Steven B Heymsfield
Journal:  Cell Metab       Date:  2006-10       Impact factor: 27.287

5.  Anxiolytic-like effect of the selective neuropeptide Y Y2 receptor antagonist BIIE0246 in the elevated plus-maze.

Authors:  Fabrizio Bacchi; Aleksander A Mathé; Patricia Jiménez; Luigi Stasi; Roberto Arban; Philip Gerrard; Laura Caberlotto
Journal:  Peptides       Date:  2006-09-07       Impact factor: 3.750

6.  Reduced anxiety and improved stress coping ability in mice lacking NPY-Y2 receptors.

Authors:  Alexandra Tschenett; Nicolas Singewald; Mirjana Carli; Claudia Balducci; Peter Salchner; Annamaria Vezzani; Herbert Herzog; Günther Sperk
Journal:  Eur J Neurosci       Date:  2003-07       Impact factor: 3.386

7.  Characterization of neuropeptide Y, Y(2) receptor knockout mice in two animal models of learning and memory processing.

Authors:  John Paul Redrobe; Yvan Dumont; Herbert Herzog; Rémi Quirion
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

8.  Reduced anxiety-like and depression-related behavior in neuropeptide Y Y4 receptor knockout mice.

Authors:  E Painsipp; T Wultsch; M E Edelsbrunner; R O Tasan; N Singewald; H Herzog; P Holzer
Journal:  Genes Brain Behav       Date:  2008-07       Impact factor: 3.449

9.  Continuous intraventricular infusion of neuropeptide Y evokes episodic food intake in satiated female rats: effects of adrenalectomy and cholecystokinin.

Authors:  S P Kalra; M G Dube; P S Kalra
Journal:  Peptides       Date:  1988 Jul-Aug       Impact factor: 3.750

10.  Characterization of N-(1-Acetyl-2,3-dihydro-1H-indol-6-yl)-3-(3-cyano-phenyl)-N-[1-(2-cyclopentyl-ethyl)-piperidin-4yl]acrylamide (JNJ-5207787), a small molecule antagonist of the neuropeptide Y Y2 receptor.

Authors:  Pascal Bonaventure; Diane Nepomuceno; Curt Mazur; Brian Lord; Dale A Rudolph; Jill A Jablonowski; Nicholas I Carruthers; Timothy W Lovenberg
Journal:  J Pharmacol Exp Ther       Date:  2003-11-14       Impact factor: 4.030

View more
  19 in total

1.  Hippocampal Y2 receptor-mediated mossy fiber plasticity is implicated in nicotine abstinence-related social anxiety-like behavior in an outbred rat model of the novelty-seeking phenotype.

Authors:  Cigdem Aydin; Ozge Oztan; Ceylan Isgor
Journal:  Pharmacol Biochem Behav       Date:  2014-08-23       Impact factor: 3.533

2.  Effects of a selective Y2R antagonist, JNJ-31020028, on nicotine abstinence-related social anxiety-like behavior, neuropeptide Y and corticotropin releasing factor mRNA levels in the novelty-seeking phenotype.

Authors:  Cigdem Aydin; Ozge Oztan; Ceylan Isgor
Journal:  Behav Brain Res       Date:  2011-04-08       Impact factor: 3.332

3.  Role of peptide YY(3-36) in the satiety produced by gastric delivery of macronutrients in rats.

Authors:  Roger Reidelberger; Alvin Haver; Prasanth K Chelikani
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-03-12       Impact factor: 4.310

Review 4.  Neuropeptide Y and posttraumatic stress disorder.

Authors:  R Sah; T D Geracioti
Journal:  Mol Psychiatry       Date:  2012-07-17       Impact factor: 15.992

5.  Neuropeptide Y Y2 antagonist treated ovariectomized mice exhibit greater bone mineral density.

Authors:  K L Seldeen; P G Halley; C H Volmar; M A Rodríguez; M Hernandez; M Pang; S K Carlsson; L J Suva; C Wahlestedt; B R Troen; S P Brothers
Journal:  Neuropeptides       Date:  2017-11-07       Impact factor: 3.286

6.  Peptide YY3-36 and 5-hydroxytryptamine mediate emesis induction by trichothecene deoxynivalenol (vomitoxin).

Authors:  Wenda Wu; Melissa A Bates; Steven J Bursian; Brenna Flannery; Hui-Ren Zhou; Jane E Link; Haibin Zhang; James J Pestka
Journal:  Toxicol Sci       Date:  2013-03-01       Impact factor: 4.849

Review 7.  Ligands of the neuropeptide Y Y2 receptor.

Authors:  Gopi Kumar Mittapalli; Edward Roberts
Journal:  Bioorg Med Chem Lett       Date:  2013-12-04       Impact factor: 2.823

8.  Neuropeptide YY(2)R blockade in the central amygdala reduces anxiety-like behavior but not alcohol drinking in alcohol-dependent rats.

Authors:  Marsida Kallupi; Leandro F Vendruscolo; Casey Y Carmichael; Olivier George; George F Koob; Nicholas W Gilpin
Journal:  Addict Biol       Date:  2013-05-03       Impact factor: 4.280

Review 9.  Corticotropin-releasing factor (CRF) and neuropeptide Y (NPY): effects on inhibitory transmission in central amygdala, and anxiety- & alcohol-related behaviors.

Authors:  Nicholas W Gilpin
Journal:  Alcohol       Date:  2012-05-04       Impact factor: 2.405

10.  Dynamics of Gut-Brain Communication Underlying Hunger.

Authors:  Lisa R Beutler; Yiming Chen; Jamie S Ahn; Yen-Chu Lin; Rachel A Essner; Zachary A Knight
Journal:  Neuron       Date:  2017-10-11       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.